AAAAAA

   
Results: 1-19 |
Results: 19
Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors
Authors: Barzon, L Chilosi, M Fallo, F Martignoni, G Montagna, L Palu, G Boscaro, M
Citation: L. Barzon et al., Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors, EUR J ENDOC, 145(2), 2001, pp. 207-212
Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas
Authors: Barzon, L Fallo, F Sonino, N Boscaro, M
Citation: L. Barzon et al., Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas, EUR J ENDOC, 145(2), 2001, pp. 223-224
Cushing's syndrome
Authors: Boscaro, M Barzon, L Fallo, F Sonino, N
Citation: M. Boscaro et al., Cushing's syndrome, LANCET, 357(9258), 2001, pp. 783-791
Multiple endocrine neoplasia type 1 and adrenal lesions
Authors: Barzon, L Pasquali, C Grigoletto, C Pedrazzoli, S Boscaro, M Fallo, F
Citation: L. Barzon et al., Multiple endocrine neoplasia type 1 and adrenal lesions, J UROL, 166(1), 2001, pp. 24-27
Considerations in diagnosis at Cushing syndrome - Reply
Authors: Boscaro, M Barzon, L Sonino, N
Citation: M. Boscaro et al., Considerations in diagnosis at Cushing syndrome - Reply, ARCH IN MED, 161(14), 2001, pp. 1780-1780
New perspectives for gene therapy in endocrinology
Authors: Barzon, L Bonaguro, R Palu, G Boscaro, M
Citation: L. Barzon et al., New perspectives for gene therapy in endocrinology, EUR J ENDOC, 143(4), 2000, pp. 447-466
A clinical index for rating severity in Cushing's syndrome
Authors: Sonino, N Boscaro, M Fallo, F Fava, GA
Citation: N. Sonino et al., A clinical index for rating severity in Cushing's syndrome, PSYCHOTH PS, 69(4), 2000, pp. 216-220
Diagnosis and management of adrenal incidentalomas
Authors: Barzon, L Boscaro, M
Citation: L. Barzon et M. Boscaro, Diagnosis and management of adrenal incidentalomas, J UROL, 163(2), 2000, pp. 398-407
The diagnosis of Cushing's syndrome - Atypical presentations and laboratory shortcomings
Authors: Boscaro, M Barzon, L Sonino, N
Citation: M. Boscaro et al., The diagnosis of Cushing's syndrome - Atypical presentations and laboratory shortcomings, ARCH IN MED, 160(20), 2000, pp. 3045-3053
Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome
Authors: Casonato, A Pontara, E Boscaro, M Sonino, N Sartorello, F Ferasin, S Girolami, A
Citation: A. Casonato et al., Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome, BL COAG FIB, 10(3), 1999, pp. 145-151
Medical therapy for Cushing's disease
Authors: Sonino, N Boscaro, M
Citation: N. Sonino et M. Boscaro, Medical therapy for Cushing's disease, END METAB C, 28(1), 1999, pp. 211
Regression of cardiac abnormalities after replacement therapy in Addison'sdisease
Authors: Fallo, F Betterle, C Budano, S Lupia, M Boscaro, M Sonino, N
Citation: F. Fallo et al., Regression of cardiac abnormalities after replacement therapy in Addison'sdisease, EUR J ENDOC, 140(5), 1999, pp. 425-428
Slow-release lanreotide treatment in acromegaly: Effects on quality of life
Authors: Sonino, N Scarpa, E Paoletta, A Fallo, F Boscaro, M
Citation: N. Sonino et al., Slow-release lanreotide treatment in acromegaly: Effects on quality of life, PSYCHOTH PS, 68(3), 1999, pp. 165-167
Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease
Authors: Arvat, E Ramunni, J Maccagno, B Giordano, R Broglio, F Deghenghi, R Boscaro, M Ghigo, E
Citation: E. Arvat et al., Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease, NEUROENDOCR, 70(3), 1999, pp. 200-206
Inactivation of the p16 tumor suppressor gene in adrenocortical tumors
Authors: Pilon, C Pistorello, M Moscon, A Altavilla, G Pagotto, U Boscaro, M Fallo, F
Citation: C. Pilon et al., Inactivation of the p16 tumor suppressor gene in adrenocortical tumors, J CLIN END, 84(8), 1999, pp. 2776-2779
Comment - Is there a role for low doses of mitotane (o,p '-DDD) as adjuvant therapy in adrenocortical carcinoma?
Authors: Barzon, L Fallo, F Sonino, N Daniele, O Boscaro, M
Citation: L. Barzon et al., Comment - Is there a role for low doses of mitotane (o,p '-DDD) as adjuvant therapy in adrenocortical carcinoma?, J CLIN END, 84(4), 1999, pp. 1488-1488
Risk factors and long-term follow-up of adrenal incidentalomas
Authors: Barzon, L Scaroni, C Sonino, N Fallo, F Paoletta, A Boscaro, M
Citation: L. Barzon et al., Risk factors and long-term follow-up of adrenal incidentalomas, J CLIN END, 84(2), 1999, pp. 520-526
Mutations in CYP11B1 gene converting 11 beta-hydroxylase into an aldosterone-producing enzyme are not present in aldosterone-producing adenomas
Authors: Pilon, C Mulatero, P Barzon, L Veglio, F Garrone, C Boscaro, M Sonino, N Fallo, F
Citation: C. Pilon et al., Mutations in CYP11B1 gene converting 11 beta-hydroxylase into an aldosterone-producing enzyme are not present in aldosterone-producing adenomas, J CLIN END, 84(11), 1999, pp. 4228-4231
Life events and neurocirculatory asthenia. A controlled study
Authors: Sonino, N Fava, GA Boscaro, M Fallo, F
Citation: N. Sonino et al., Life events and neurocirculatory asthenia. A controlled study, J INTERN M, 244(6), 1998, pp. 523-528
Risultati: 1-19 |